Suppression of Vascular Endothelial Growth Factor (VEGF) Expression by Targeting the Bcr-Abl Oncogene and Protein Tyrosine Kinase Activity in Bcr-Abl-positive Leukaemia Cells

By Li L   Zhang R   Fang ZY   Chen JN   Zhu ZL  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 426-437

Field House Publishing

Access to resources Recommend Favorite

Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells

By Riva L.   Galzin A.-M.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

Vascular endothelial growth factor tyrosine kinase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 921-924

Informa Healthcare

Access to resources Recommend Favorite

Is EDHF an epoxyeicosatrienoic acid?

By Quilley J.   McGiff J.C.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 121-124

Elsevier

Access to resources Recommend Favorite

Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor

By Wejksza Katarzyna   Rzeski Wojciech   Parada-Turska Jolanta   Zdzisinska Barbara   Rejdak Robert   Kocki Tomasz   Okuno Etsuo   Kandefer-Szerszen Martyna   Zrenner Eberhart   Turski Waldemar  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 3, 2004-03 ,pp. : 300-304

Springer Publishing Company

Access to resources Recommend Favorite